Detailed price information for Phio Pharmaceuticals Corp (PHIO-Q) from The Globe and Mail including charting and trades.
Outsource high-potency ADC manufacturing to specialized CDMOs to reduce capital investment, access containment infrastructure, and accelerate clinical-to-commercial scale-up.Dublin, Oct. (GLOBE ...
Medical cannabis active pharmaceutical ingredient manufacturer NeoCannBio signed a memorandum of understanding on October 12, ...
HarbinPharmaceutical (SHA:600664) subsidiary Harbin Pharmaceutical Group Bioengineering obtained a drug registration approval ...
North Gyeongsang Province plans to invest about 175 billion won ($131 million) to build a controlled-drug industry hub in ...
A newly released Bentham Books volume examines how eutectic mixtures can enhance the solubility, dissolution, and ...
MitoCareX enhances bioinformatics capabilities to improve disease analysis in drug discovery processes through expert ...
Dublin, Oct. (GLOBE NEWSWIRE) -- "Active Pharmaceutical Ingredients Market Report by Drug Type, Synthesis, Type of Manufacturer, Application, Country and Company Analysis 2026-2034" has been added to ...
The alchemy of culling and plunder woven by massive patent losses and the 158 yen-to-dollar rangeGreetings, investors. This ...
Axis Direct initiates coverage on Aarti Drugs with a BUY rating and a target of Rs 454, fueled by capacity expansion and ...
OpenAI's API pricing page has quietly added an unannounced life sciences model called gpt-rosalind-discovery, priced identically to the ...
Occasionally, an innovation comes along that causes consumers to significantly alter their habits or behavior. When that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results